Skip to main content
Russell Ware, MD, Pediatric Hematology & Oncology, Cincinnati, OH, Cincinnati Children's Hospital Medical Center

RussellEWareMDPhD

Pediatric Hematology & Oncology • Cincinnati, OH

Director, Division of Hematology Marjory J. Johnson Chair of Hematology Translational Research, Division of Hematology Co-Executive Director, Cancer and Blood Diseases Institute Associate Director

Join to view full profile

Dr. Ware is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ware's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1986 - 1989
  • Baylor College of Medicine (Houston)
    Baylor College of Medicine (Houston)Residency, Pediatrics, 1983 - 1986
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1983

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2013 - 2025
  • TN State Medical License
    TN State Medical License 2004 - 2023
  • TX State Medical License
    TX State Medical License 2012 - 2014
  • NC State Medical License
    NC State Medical License 1987 - 2005
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Effects of Hydroxyurea Treatment on Malaria Infections in Sub-Saharan Africa
    Russell E. Ware, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Genetic Analysis in the Tanzania Sickle Surveillance Study (TS3): Modifiers of Sickle Cell Disease and Identification of Hemoglobin Variants
    Russell E. Ware, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Profound Alteration of Host Response in Severe Malarial Anemia By Sickle Cell Disease: Reduction of Parasite Sequestration and Inflammation, Upregulation of Angiopoiet...
    Russell E. Ware, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Concomitant Hydroxyurea and Voxelotor: Results from the HOPE Study 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Old and New Treatments for Sickle Cell Anemia: Is There a Standard of Care? 
    60th American Society of Hematology Annual Meeting - 11/30/2018

Other

Press Mentions

  • NIH Funds New Project to Improve SCD Care for Children in Malawi
    NIH Funds New Project to Improve SCD Care for Children in MalawiNovember 10th, 2020
  • These Companies Are Seeking a Cure for Sickle Cell. And It’s Just the Beginning for Some Gene Therapy Stocks
    These Companies Are Seeking a Cure for Sickle Cell. And It’s Just the Beginning for Some Gene Therapy StocksJuly 24th, 2020
  • Higher Hydroxyurea Dose Does NOHARM in Sub-Saharan African Children with Sickle Cell Disease
    Higher Hydroxyurea Dose Does NOHARM in Sub-Saharan African Children with Sickle Cell DiseaseJuly 22nd, 2020
  • Join now to see all

Grant Support

  • TCD With Transfusions Changing To HydroxyureaNational Heart, Lung, And Blood Institute2011
  • Sparing Conversion To Abnormal TCD ElevationNational Heart, Lung, And Blood Institute2011
  • Hydroxyurea Pharmacokinetics And PharmacogenomicsNational Heart, Lung, And Blood Institute2011
  • Sickle Cell Scholar ComponentNational Heart, Lung, And Blood Institute2008–2011
  • Administrative CoreNational Heart, Lung, And Blood Institute2008–2011
  • Sparing Conversion To Abnormal TCD ElevationNational Heart, Lung, And Blood Institute2010
  • TCD With Transfusions Changing To HydroxyureaNational Heart, Lung, And Blood Institute2009–2010
  • Hydroxyurea Pharmacokinetics And PharmacogenomicsNational Heart, Lung, And Blood Institute2008–2010
  • Stroke With Transfusions Changing To HydroxyureaNational Heart, Lung, And Blood Institute2005–2010
  • Comprehensive Sickle Cell Center Composite:Basic &Translational Research ProgramNational Heart, Lung, And Blood Institute2009
  • Comprehensive Sickle Cell Center CompositeNational Heart, Lung, And Blood Institute2008
  • Core--Clinical CoreNational Heart, Lung, And Blood Institute2007
  • Genetic Modifiers In Children With Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2004–2005
  • Genetic Modifiers In Children With Sickle Cell AnemiaNational Heart, Lung, And Blood Institute2001–2003
  • Abnormal PIG A Expression In GPI Deficient Blood CellsNational Heart, Lung, And Blood Institute1995–1999
  • Biology Of The Bone Marrow Derived 3A1 Stem CellNational Heart, Lung, And Blood Institute1987–1991

Hospital Affiliations

Dr. Russell Ware, Dr. Russell Ware, MD, Dr. R Ware, Dr. Russell E Ware